Creative Medical Technology Holdings, Inc. SEC filings CELZ
Creative Medical Technology Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Sep 13, 2002. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K/A | Amended annual report | Apr 24, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 20, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Apr 25, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 4, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Mar 19, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 14, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 29, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 17, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Apr 6, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Jun 28, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Jun 20, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Apr 1, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 29, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 13, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Apr 14, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Feb 27, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 17, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 15, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 26, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 31, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Feb 3, 2010 | Dec 31, 2009 |
| 10-K | Annual report | May 14, 2009 | Dec 31, 2008 |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CELZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Phoenix, AZ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1187953
- Former names
- JOLLEY MARKETING INC (until May 13, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.